Cipla donates Rs 25 crores in battle against corona Ruchika Sharma24 April 2020 11:55 AM ISTNew Delhi: Drugs maker Cipla on Tuesday said it has pledged Rs 25 crore to support the government in combating the coronavirus pandemic.This includes...
Cipla organizes home delivery of its OTC products; ties with Zomato, Swiggy Ruchika Sharma17 April 2020 12:19 PM ISTMumbai: Startup Cipla Health, a subsidiary of Cipla, on Wednesday said it has partnered with Swiggy, Zomato and Dunzo for home deliveries of...
Pantocid DSR found of Substandard Quality- Drug Regulator Ruby12 Aug 2018 11:12 PM ISTRajasthan: The quality of some of the commonly used medicines in India including antacids and anti-allergics have been found to be substandard after...
Soon, GST on Pharmaceutical companies freebies Ruby1 July 2018 10:35 AM ISTMumbai: Pharmaceutical companies may come under the lens of GST for offering freebies and trade schemes, according to a recent media report.ET...
PM push for generic drugs to shift focus to chemists, says Indian Pharmaceutical Alliance savita19 April 2017 3:22 PM ISTNEW DELHI: Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines as indicated by...
Cipla acquires two US drug firms for $550 mn savita19 Feb 2016 8:16 AM ISTDrug major Cipla has acquired two US-based firms -- InvaGen Pharmaceuticals and Exelan Pharmaceuticals -- for $550 million, the company said in a...
Govt approves investment by FIL Capital in Cipla Health savita17 Feb 2016 8:16 AM ISTNew Delhi : Drug major Cipla said the government has approved an investment by Mauritius-based FIL Capital Investments in its subsidiary, Cipla Health...
Cipla gets CCI nod to sell 26 percent in consumer healthcare business savita29 Jan 2016 8:33 AM ISTNEW DELHI: Drug major Cipla has received approval from fair trade regulator CCI to sell about 26 per cent stake in its consumer healthcare business to...
Cipla completes stake sale in Biomab Holding savita23 Jan 2016 11:54 AM ISTNEW DELHI: Drug major Cipla announced completion of selling its entire holding in Hong Kong-based Biomab Holding to Biomab Brilliant for $ 2.5...
Cipla gets CCI nod for investment by FIL Capital savita22 Jan 2016 11:30 AM ISTNew Delhi: Drug major Cipla said it has received approval from competition watchdog CCI over the proposed investment by Mauritius-based FIL Capital...
Over 200 drugs under development, top 50 with $30 billion potential: Cipla savita14 Jan 2016 11:15 AM ISTNew Delhi : Charting out its next phase of growth, homegrown drug major Cipla is banking on over 200 drugs under development out of which "top 50...
Cipla inks pact with US firm for Ropivacaine infusion system savita7 Jan 2016 11:01 AM ISTNew Delhi: Drug major Cipla has inked a pact with US-based BioQ Pharma for registration and commercialisation of latter's Ropivacaine infusion system,...
